- Yahoo Finance
Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations
The Biden administration revealed the first 10 drugs that will face the Medicare negotiation process under the Inflation Reduction Act.
- Yahoo Finance
Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS
UBS believes there is little chance the lawsuits brought on by pharma companies will delay Medicare pricing negotiations.
